The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for A M Surgical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
AM Surgical is a medical device company that manufactures and markets endoscopic instruments. The company’s products comprise endoscopic carpal tunnel release system, endoscopic cubital tunnel release system, the CPX, clear cannula, and scope-mounting blade. AM Surgical endoscopic soft tissue release system used for cubital and carpal tunnel release surgery and its endoscopic cubital tunnel release system offers a minimally invasive treatment option for decompression of the ulnar nerve. The company’s clear Cannula offers views of anatomy throughout the endoscopic portion of both cubital and carpal tunnel release. AM Surgical is headquartered in Smithtown, New York, the US.
The key metrics of A M Surgical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As A M Surgical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as A M Surgical.
For a detailed understanding of the performance of A M Surgical, buy the report here.